KKR Nears Deal to Acquire Integer Holdings, Sends Stock Soaring
KKR is nearing a deal to acquire Integer Holdings, prompting a significant increase in the company's stock price. The deal is expected, although no official announcement has been made.
Integer Holdings stock surged as much as 20% in afternoon trading on Friday, July 31, 2026 after the Wall Street Journal reported that private equity firm KKR is nearing a deal to take the medical-device contract manufacturer private. The report, citing people familiar with the matter, said KKR's offer would value Integer at about $127 a share, or roughly $4.3 billion based on the company's 33.95 million shares outstanding, and that a deal could be announced as soon as next week. As of this writing neither KKR nor Integer has confirmed the report, so this is a reported deal in progress, not a signed agreement.
Integer, based in Plano, Texas, is one of the largest medical-device contract development and manufacturing organizations in the world, serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets under brands including Greatbatch Medical and Lake Region Medical. A buyout would hand KKR one of the largest independent medtech outsourcing platforms left in the sector, at a moment when private equity has been circling healthcare and diagnostics assets.
The reported approach fits a broader wave of private-equity buyouts in healthcare this year: Blackstone and TPG agreed to acquire diagnostics maker Hologic for more than $18 billion, and American Industrial Partners agreed to buy Avanos Medical for $1.27 billion. Integer shares touched a new 52-week high of $123.50 during Friday's rally, still below the reported $127 offer price, leaving room for the stock to move further if a formal deal is announced at that level or higher.
Investors should watch for a signed agreement, which the Journal's sourcing suggests could land within days, along with the final per-share price, financing terms, and whether Integer's board is negotiating exclusively with KKR or fielding other bidders. Until KKR or Integer files anything with the SEC confirming a transaction, the deal, and the premium it implies, remains unconfirmed.
Related Stocks
Powered by SentiSense - Intelligent Market Analysis